A study by the Boston Consulting Group shows that drug candidate molecules discovered through AI have been 80-90% successful in Phase I clinical trials.
Delia Niculescu
Current Affairs
foto:pixabay
Always see our news on Google
According to the study, molecules discovered using AI were significantly more successful in the early phases of experiments compared to the pharmaceutical industry average. This could lead to an increase in the number of successful drugs. AI has the potential to double the effectiveness of pharmaceutical research and development, contributing to the discovery of more drugs and vaccines.
Latest News
22:58
Russia warns of a resumption of nuclear testing and threatens “proportionate countermeasures”
22:47
Traian Băsescu: “If I were in the Government, tomorrow I would cancel all bonuses”
22:36
The company backed by Erik Trump failed to pay its employees on time after a $4.6 million loan was granted to its CEO
22:23
A man died after being hit by an ambulance in England
22:15
AUR's vision regarding Romania's administrative-territorial reform
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
